Injectable Imiglucerase Instructions for Use

Update: 30 October, 2023

Injectable Imiglucerase Instructions for Use, for the long-term enzyme replacement therapy of patients with non-neuropathic (type I) and chronic neuropathic (type III) Gaucher disease who have significant non-neurological disease manifestations.


File format: PDF

Size: -

MD5 Checksum: 33A785F594715A4ACF2CDE42A91899C7

Publication date: 30 October, 2023

Downloads: -

PDF Link: Injectable Imiglucerase Instructions for Use PDF

Also Manuals